Sudershan Drugs And Intermediates Limited

Pharmaceutical manufacturing and intermediates production in Telangana since 1982.

1982 | Medak, Telangana (India) | Active
Last Updated:

Sudershan Drugs And Intermediates Profile

Key Indicators

  • Authorised Capital ₹ 13.50 Cr
  • Paid Up Capital ₹ 13.50 Cr
  • Company Age 42 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 53.00 Cr
  • Satisfied Charges ₹ 11.00 Cr
  • Revenue Growth 0.77%
  • Profit Growth -8.95%
  • Ebitda -6.01%
  • Net Worth -7.26%
  • Total Assets -0.39%

About Sudershan Drugs And Intermediates

Sudershan Drugs And Intermediates Limited (SDAIL) is a Public Limited Indian Non-Government Company incorporated in India on 30 December 1982 and has a history of 42 years and two months. Its registered office is in Medak, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 13.50 Cr and a paid-up capital of Rs 13.50 Cr.

The company currently has active open charges totaling ₹53.00 Cr. The company has closed loans amounting to ₹11.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Sudershan Drugs And Intermediates Limited India are Subbaraju Gokaraju as CFO and Priya Khetan as Company Secretary. Yoganandavenkata Subrahamanya, Appala Chilakanarri, and Subbaraju Gokaraju serve as directors at the Company.

Company Details

  • Location

    Medak, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230TG1982PLC003759

  • Company No.

    003759

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    30 Dec 1982

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

What products or services does Sudershan Drugs And Intermediates Limited offer?

Sudershan Drugs And Intermediates Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine.

Who are the key members and board of directors at Sudershan Drugs And Intermediates?

Executive Team (3)

NameDesignationAppointment DateStatus
Yoganandavenkata Subrahamanya Country flag representing In Managing Director22-Dec-2017Current
Subbaraju Gokaraju CFO01-Sep-2020Current
Priya Khetan Country flag representing In Company Secretary13-Jun-2019Current

Board Members (2)

NameDesignationAppointment DateStatus
Appala Chilakanarri Country flag representing In Director 15-May-2005Current
Subbaraju Gokaraju Country flag representing In Director 30-Sep-1994Current

Financial Performance of Sudershan Drugs And Intermediates.

Sudershan Drugs And Intermediates Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.77% increase. The company also saw a slight decrease in profitability, with a 8.95% decrease in profit. The company's net worth dipped by a decrease of 7.26%.

Sudershan Drugs And Intermediates revenue growth over time
Sudershan Drugs And Intermediates profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
0.77%
Revenue from Operations
Total Assets
-0.39%
Profit or Loss
-8.95%
Net Worth
-7.26%
EBITDA
-6.01%

What is the Ownership and Shareholding Structure of Sudershan Drugs And Intermediates?

In 2023, Sudershan Drugs And Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹53.00 Cr

Satisfied Charges

₹11.00 Cr

Charges Breakdown by Lending Institutions

  • Gr Intrachem Ltd : 29.00 Cr
  • Canara Bank : 20.00 Cr
  • The Industrial Credit & Investment Corp. Of India Ltd : 3.50 Cr
  • State Bank Of India : 0.50 Cr

Latest Charge Details

DateLenderAmountStatus
27 Dec 2000Gr Intrachem Ltd₹12.00 CrOpen
30 Mar 2000Gr Intrachem Ltd₹5.00 CrOpen
06 Dec 1997Canara Bank₹20.00 CrOpen
10 Mar 1995Gr Intrachem Ltd₹12.00 CrOpen
17 Jul 1993State Bank Of India₹5.00 MOpen

How Many Employees Work at Sudershan Drugs And Intermediates?

Unlock and access historical data on people associated with Sudershan Drugs And Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Sudershan Drugs And Intermediates Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sudershan Drugs And Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sudershan Drugs And Intermediates's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Sudershan Drugs And Intermediates

Recent activity within the organization

  • Annual General Meeting

    Sudershan Drugs And Intermediates Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Sudershan Drugs And Intermediates Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Director Appointment

    Subbaraju Gokaraju was appointed as a Cfo was appointed as a Cfo on 01 Sep 2020 & has been associated with this company since 4 years 6 months .

  • Director Appointment

    Priya Khetan was appointed as a Company Secretary was appointed as a Company Secretary on 13 Jun 2019 & has been associated with this company since 5 years 8 months .

  • Director Appointment

    Yoganandavenkata Somayajulu Nuthi Subrahamanya was appointed as a Managing Director was appointed as a Managing Director on 22 Dec 2017 & has been associated with this company since 7 years 2 months .

  • Charges

    A charge registered on 06 Mar 2000 via Charge ID 90124640 with The Banares State Bank Ltd was fully satisfied on 06 Dec 2008.

Frequently asked questions

  • What is the Incorporation or founding date of Sudershan Drugs And Intermediates Limited?

    Sudershan Drugs And Intermediates Limited was incorporated on 30 Dec 1982.

  • What is authorized share capital and paid-up capital of Sudershan Drugs And Intermediates Limited?

    The authorized share capital of Sudershan Drugs And Intermediates Limited is ₹ 13.50 Cr and paid-up capital is ₹ 13.50 Cr.

  • Who are the current board members & directors of Sudershan Drugs And Intermediates Limited?

    Currently 5 directors are associated with Sudershan Drugs And Intermediates Limited.

    • Yoganandavenkata Somayajulu Nuthi Subrahamanya
    • Appala Charyulu Chilakanarri
    • Subbaraju Gokaraju
    • Subbaraju Gokaraju
    • Priya Khetan

  • What is the registered address of Sudershan Drugs And Intermediates Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Sudershan Drugs And Intermediates Limited is Kanukunta Jinnaram Mandal Village India, Kanukunta Village, Telangana, 502313.

  • What is the corporate identification number (CIN) and company number of Sudershan Drugs And Intermediates Limited?

    The corporate identification number (CIN) of Sudershan Drugs And Intermediates Limited is U24230TG1982PLC003759 and the company number is 003759 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Sudershan Drugs And Intermediates Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Sudershan Drugs And Intermediates Limited has risen by 0.77%.

  • What change has been observed in the net worth of Sudershan Drugs And Intermediates Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Sudershan Drugs And Intermediates Limited has experienced an downturn of -7.26%.

  • What are the total open charges for Sudershan Drugs And Intermediates Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Sudershan Drugs And Intermediates Limited amount to ₹ 53.00 Cr.

  • When was the last Balance Sheet of Sudershan Drugs And Intermediates Limited filed with the ROC?

    The most recent Balance Sheet for Sudershan Drugs And Intermediates Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development